Evidence map›Paper›PMID 22693569›Full record

ArticlePloS one2012

Glycerol supplementation enhances L. reuteri's protective effect against S. Typhimurium colonization in a 3-D model of colonic epithelium.

Rosemarie De Weirdt, Aurélie Crabbé, Stefan Roos, Sabine Vollenweider, Christophe Lacroix, Jan Peter van Pijkeren, Robert A Britton, Shameema Sarker, Tom Van de Wiele, Cheryl A Nickerson

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. The Role of ProbioticsInternational journal of molecular sciences · 2026
    Review
  5. International journal of molecular sciences · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. The role of potential probiotic strainsFrontiers in microbiology · 2023
    Review
  12. Review
  13. Article
  14. Spaceflight Analogue Culture Enhances the Host-Pathogen Interaction BetweenFrontiers in cellular and infection microbiology · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

Rosemarie De WeirdtLaboratory of Microbial Ecology and Technology (LabMET), Ghent University, Ghent, Belgium.
Aurélie Crabbé
Stefan Roos
Sabine Vollenweider
Christophe Lacroix
Jan Peter van Pijkeren
Robert A Britton
Shameema Sarker
Tom Van de Wiele
Cheryl A Nickerson
Arizona State University · USETH Zurich · CHMichigan United · USGhent University · BEGhent University Hospital · BESwedish University of Agricultural Sciences · SE

Funding

The Impact of Microbiome Composition, Diversity, and Function on Enteric DiseaseU19AI090872 · NIAID · MICHIGAN STATE UNIVERSITY · PI MANSFIELD, LINDA S. · 2010 to 2014
$7.1M
NIAID NIH HHS U19 AI090872
6 · The paper itself

Abstract

The probiotic effects of Lactobacillus reuteri have been speculated to partly depend on its capacity to produce the antimicrobial substance reuterin during the reduction of glycerol in the gut. In this study, the potential of this process to protect human intestinal epithelial cells against infection with Salmonella enterica serovar Typhimurium was investigated. We used a three-dimensional (3-D) organotypic model of human colonic epithelium that was previously validated and applied to study interactions between S. Typhimurium and the intestinal epithelium that lead to enteric salmonellosis. Using this model system, we show that L. reuteri protects the intestinal cells against the early stages of Salmonella infection and that this effect is significantly increased when L. reuteri is stimulated to produce reuterin from glycerol. More specifically, the reuterin-containing ferment of L. reuteri caused a reduction in Salmonella adherence and invasion (1 log unit), and intracellular survival (2 log units). In contrast, the L. reuteri ferment without reuterin stimulated growth of the intracellular Salmonella population with 1 log unit. The short-term exposure to reuterin or the reuterin-containing ferment had no observed negative impact on intestinal epithelial cell health. However, long-term exposure (24 h) induced a complete loss of cell-cell contact within the epithelial aggregates and compromised cell viability. Collectively, these results shed light on a potential role for reuterin in inhibiting Salmonella-induced intestinal infections and may support the combined application of glycerol and L. reuteri. While future in vitro and in vivo studies of reuterin on intestinal health should fine-tune our understanding of the mechanistic effects, in particular in the presence of a complex gut microbiota, this the first report of a reuterin effect on the enteric infection process in any mammalian cell type.

Indexed as

Dietary SupplementsCell SurvivalColonCulture Media, ConditionedFermentationGlyceraldehydeGlycerolHT29 CellsHumansIntestinal MucosaLimosilactobacillus reuteriModels, MolecularPropaneSalmonella typhimurium3-hydroxypropionaldehydeCulture Media, ConditionedGlyceraldehydeGlycerolPropane

Identifiers

PMID22693569
PMCPMC3365044
OpenAlexW2033436530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.